posted from: http://integrateddiabetes.com/tresiba-gains-fda-approval-for-use-in-children-and-adolescents/

Children and adolescents age 1 and up now have another option in basal insulin. On December 19, 2016, Novo Nordisk announced that the FDA approved an expanded indication for Tresiba (insulin degludec injection 100 U/mL, 200 U/mL).